JOINT TRANSNATIONAL CALL 2020
“Multidisciplinary Research Projects on Personalised Medicine – Pre-/Clinical research, Big Data and ICT, Implementation and User’s Perspective”
Deadline for pre-proposal submission is: 5 March 2020 (17:00 CET)
ERA PerMed is an ERA-NET Cofund, supported by 32 partners of 23 countries and cofunded by the European Commission (EC). To align national research strategies, promote excellence, reinforce the competitiveness of European players in Personalised Medicine (PM), and enhance the European collaboration with non-EU countries, 31 funding organisations have agreed to launch the third Joint Transnational Call for research projects in PM. This represents the second of three additional calls non-cofunded by the EC. The funding organisations participating in this call particularly wish to promote innovative interdisciplinary collaboration and to encourage translational research proposals. The available budget for this call is 27 Mio € (approx.).
Opening of online submission tool: likely on 16 December 2019
Submission deadline for pre-proposals: 5 March 2020 (17:00 CET)
Submission deadline for full-proposals: 15 June 2020 (17:00 CEST)
Electronic submission website
Electronic proposal submission is mandatory on PT-Outline. Research project consortia who intend to submit a transnational proposal should register as soon as possible, by clicking on “Sign up” and follow further instructions.
Contact persons for the Joint Call Secretariat (JCS)
The ERA PerMed JCS is hosted by the German Aerospace Center e.V. – Project Management Agency, (DLR-PT):
Katja Kuhlmann, Alexandra Becker
Heinrich-Konen-Straße 1, 53227 Bonn, GERMANY
Tel +49 (0) 228 3821 2211
The call text and all additional documents can be downloaded below or on the online submission tool:
Call Text (updated 23-12-2019)
Guidelines for Applicants (updated 19-12-2019)
Pre-Proposal form (updated 18-12-2019)
ITALY (IT-MoH): Pre-eligibility check form for IT-MoH proposals(to be sent to IT-MoH at least 10 working days before the JTC submission deadline)
ITALY (FRRB): Pre-eligibility check form for FRRB proposals (to be sent to FRRB at least 10 working days before the JTC submission deadline) and budget tool as support for FRRB applicants
ITALY (TuscReg): Pre-eligibility check form for TuscReg proposals and budget compilation form for TuscReg proposals (both to be sent to TuscReg at least 10 working days before the JTC submission deadline)
SPAIN (ISCIII and FCAECC): Additional application form for partners requesting funds from ISCIII and FCAECC (updated 23-12-2019) (to be sent as annex of the pre-proposal submission form via the online submission tool)
AIMS OF THE CALL
With its third transnational call (non-cofunded by the EC), ERA PerMed fosters research and innovation activities that build close linkages between basic biomedical research, clinical research, physical sciences, bioengineering, bioinformatics and biostatistics, epidemiology, socio-economic research, as well as research on the integration of PM into clinical practice and on ethical, legal and social implications across the participating countries and beyond. This implies a wide range of multidisciplinary activities brought together by different stakeholders from academia (e.g. universities and research institutions), clinics (e.g. clinical laboratories, medical professionals), industry (e.g. pharmaceutical industry, biotechnology companies, information technology companies including health information technology – HIT), policy makers, regulatory/health technology assessment (HTA) agencies and patients/patient organisations.
The overarching goal is to improve disease prevention and disease management, based on broader and more efficiently characterised and defined patient stratification, diagnostics and tailored treatment protocols. Early involvement of regulatory authorities and close interaction with the different key players along the value chain should be included right from the project development phase to bridge the gap between first discoveries or inventions until market access. Proposals submitted under this call are expected to demonstrate the applicability of project outcomes to clinical practice. The clinical relevance of the proposed PM approach needs to be convincingly demonstrated. Moreover, proposals are expected to include research on ethical, legal and socio-economic implications, including health economics and regulation, and/or research on the optimisation of health care systems. They may also consider patient and citizen empowerment and training strategies for the different stakeholders in PM.
The overall objectives of the call are to:
Support translational research projects in the field of Personalised Medicine;
Encourage and enable interdisciplinary collaborations towards the implementation of PM, combining pre-clinical and/or clinical research with bioinformatics components and research on relevant ethical, legal and social aspects and/or research on the optimisation of health care systems;
Encourage collaboration between academia (research teams from universities, higher education institutions, public research institutions), clinical/public health research (research teams from hospital/ public health, health care settings and other health care organisations), private partners e.g. SMEs (small and medium-sized enterprises) as well as policy makers, regulatory/HTA agencies and patient organisations.
Scope OF THE CALL
Proposals must be interdisciplinary and clearly demonstrate the potential impact in PM as well as the added value of transnational collaboration.
The JTC2020 of ERA PerMed will comprise three Research Areas:
Each project proposal MUST address at least one module of Research Area 3 and at least one module of Research Area 1 or 2. The coherent integration and combination of the different Research Areas and Modules in the proposals will be part of the evaluation process.
GENERAL (eligibility) CONDITIONS FOR APPLICATION
Joint research proposals may be submitted by applicants belonging to one of the following categories (A, B and/or C), if eligible according to their respective regional/national funding organisation’s regulations for research funding:
Academia (research teams working in universities, other higher education institutions) or research institutes;
Clinical/public health sector (research teams working in hospitals/public health and/or other health care settings and health organisations). Participation of clinicians (e.g. medical doctors, nurses) in the research teams is encouraged;
(Industry) Private partners, e.g. SMEs (small and medium-size enterprises).
Although proposals will be submitted jointly by research groups from several regions/countries, research groups will be funded by the respective funding organisation of the region/country from which they have applied. Applicants are therefore subject to the eligibility criteria of their respective funding organisations. Applicants are strongly advised to contact their regional/national representatives of the participating relevant funding organisation as soon as possible in order to confirm their eligibility (see also “Contact details of participating members”).
Only transnational projects will be funded. Each consortium submitting a proposal must involve at least three partners eligible for funding coming from three different countries whose funders participate in the call (see list below). All three legal entities must be independent of each other. At least two partners of the consortium must be from two different EU Member States or Associated Countries.